References

  1. Pastores GM, Weinreb NJ, Aerts H, Andria G, et al. Therapeutic Goals in the Treatment of Gaucher Disease. Seminars in Hematol.2004; 41(5): 4-14. PubMed | Google Scholar

  2. Mistry PK, Maria DC, Elena Lukina, et al. Consensus Conference: a reappraisal of Gaucher disease - diagnosis and disease management algorithms. Am J Hematol. 2011; 10(1):110-115. PubMed | Google Scholar

  3. Capablo JL, Saenz de CA, Fraile J, et al. Neurological evaluation of Gaucher disease patients diagnosed as type 1. J Neurol Neurosurg Psychiatry. 2008; 79(2): 219-222. PubMed | Google Scholar

  4. Stirnemann J. New data on Gaucher's disease. Rev Med Int. 2008; 29:176-178. PubMed | Google Scholar

  5. Grabowski GA. Gaucher disease: lessons from a decade of therapy. J Pediatr. 2004; 144(10):15-19. PubMed | Google Scholar

  6. Sasaki Takaya, Tsukahara Shigeo. New ocular findings in Gaucher's disease: a report of two brothers. Ophtalmologica. 1985; 191(4): 206-209. PubMed | Google Scholar

  7. Aghion A. La maladie de Gaucher dans l'enfance (forme cardiorénale). Thesis, Paris (1934). Google Scholar

  8. Grabowski GA, Andria Generoso, Baldellou Antonio, et al. Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment; Consensus statements. Eur J Pediatr. 2004; 163(2): 58-66. PubMed | Google Scholar

  9. Doneda Divair, Cristina BN, Cileide CM, et al. Effects of imiglucerase on the growth and metabolism of Gaucher disease type I patients: a systematic review. Nutrit & Metab. 2013; 10(1): 34. PubMed | Google Scholar

  10. Pastores GM, Hermann G, Norton KI, et al. Regression of skeletal changes in type 1 Gaucher disease with enzyme replacement therapy. Skeletal Radiol. 1996; 25(5): 465-488. PubMed | Google Scholar

  11. Ponce Elvira, Moskovitz Jay, Grabowski Gregory. Enzyme therapy in Gaucher disease type 1: effect of neutralizing antibodies to acid β-glucosidase. Blood. 1997; 90(1): 43-48. PubMed | Google Scholar

  12. Ferrara G. Intracytoplasmic "negative images" in Gaucher cells. Acta Cytol. 1996; 40: 848-9. PubMed | Google Scholar

  13. He G, Grabowski G. Gaucher disease : A G+¹ - A+¹ IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA. Am J Hum Genet. 1992; 51(4): 810¬¬-20. PubMed | Google Scholar

  14. Chaabouni M and al. Gaucher's disease in Tunisia (multicentric study). Rev Med Int. 2004; 25(2): 104-110. PubMed | Google Scholar

  15. Rice EO, Mifflin TE, Sakallah S, et al. Gaucher disease: studies of phenotype, molecular diagnosis and treatment. Clin Genet. 1996; 49(3): 111-8. PubMed | Google Scholar

  16. Sudo M. Brain glycolipids in infantile Gaucher's disease. Neuropediatrics. 1993; 24: 237-81. PubMed | Google Scholar

  17. Prows CA, Sanchez N, Daughtery C, Grabowski GA. Gaucher disease: enzyme therapy in the acute neuropathic variant. Am J Med Genet. 1997; 71(1): 16-21. PubMed | Google Scholar

  18. Laks Y, Paswell J. The varied clinical and laboratory manifestations of type II Gaucher disease. Acta Paediatr Scand. 1987; 76(2): 378-380. PubMed | Google Scholar

  19. Bove K, Daugherty C, Grabowski G. Pathological findings in Gaucher disease type 2 patients following enzyme therapy. Hum Pathol. 1995; 26(9): 1040-1045. PubMed | Google Scholar

  20. Erikson A, Johansson K, Mansson J, et al. Enzyme replacement therapy of infantile Gaucher disease. Neuropediatrics. 1993; 24(4):237-238. PubMed | Google Scholar

  21. Germain DP, Mistry P. Phenotype variations in Gaucher disease. Rev de Med Int. 2006; 27 (Suppl 1): 7-10. PubMed | Google Scholar

  22. Beutler E, Gelbart T. Glucocerebrosidase (Gaucher disease). Hum Mutat. 1996; 8(3): 207-13. PubMed | Google Scholar

  23. Germain DP. Gaucher disease: clinical, genetic and therapeutic aspects. Pathol Bio. 2004; 52(6): 343-350. PubMed | Google Scholar

  24. Hruska KS, LaMarca ME, Sidransky E. Gaucher disease: Molecular Biology and Genotype-Phenotype Correlations. Gaucher disease. Boca Raton, FL: CRC Taylor & Francis; 2007. Gaucher Disease; pp. 13-48. Google Scholar

  25. Sidransky E, Pastores GM, Mori M. Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser? Genet Med. Feb 2009; 11(2): 90-91. PubMed | Google Scholar

  26. Mistry PK, Abrahamov Ayala. A practical approach to diagnosis and management of Gaucher's disease. Bailliers Clin Haematol. 1997; 10(4): 817-838. PubMed | Google Scholar

  27. Weinreb NJ, Deegan P, Kacena KA, Mistry P, Pastores GM, Velentgas P, et al. Life expectancy in Gaucher disease type 1. Am J Hematol. 2008; 83(12): 896-900. PubMed | Google Scholar